Google
GRAL — GRAIL, LLC (Healthcare >> Diagnostics & Research)
GRAL FAQ
What is GRAL's ROE?
GRAIL, LLC reports a Return on Equity (ROE) of -15.81%.
What is GRAL's dividend yield?
GRAIL, LLC offers a dividend yield of 0.00%.
What is GRAL's Deepscope Quality Score?
Deepscope rates GRAL's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy GRAL?
Deepscope's AI Timing Score for GRAL is 67 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does GRAL belong to?
GRAIL, LLC is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.
|
USD 59.98
Price
-6.57
(-9.87%)
Day Change
|
|
|---|
GRAL Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 31) và Thời điểm mua ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...
| Yếu tố Chất lượng |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 79 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 59.98 |
| PBV / Sector |
1.05 / -23.44
GREAT
|
| Earning Per Share | -9.04 |
| PE / Sector |
N/A / 37.86
|
| PEG or PE/Growth / Sector |
N/A / 1.41
|
| Average 1M Daily Value |
54.34 M
|
| Average 1W Daily Value |
88.12 M
|
| Yếu tố Kỹ thuật |
|
42% |
| Sức khỏe tài chính |
|
37% |
| Khả năng kiếm lợi nhuận |
|
43% |
| Lợi tức cho nhà đầu tư |
|
8% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-06 09:08:45 |
| Symbol | GRAL |
| Name | GRAIL, LLC |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 42.92 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 2,623.49 / 32,142.66 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1525 O?Brien Drive, Menlo Park, CA, United States, 94025
Phone: 833 694 2553
Website: https://grail.com
Employees: 910
Description: GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
